Shander Aryeh, Goodnough Lawrence T, Javidroozi Mazyar, Auerbach Michael, Carson Jeffrey, Ershler William B, Ghiglione Mary, Glaspy John, Lew Indu
Department of Anesthesiology, Critical Care Medicine, Pain Management and Hyperbaric Medicine, Englewood Hospital and Medical Center, Englewood, NJ; Medicine and Surgery, Mount Sinai School of Medicine, New York, NY.
Stanford University Medical Center, Stanford, CA.
Transfus Med Rev. 2014 Jul;28(3):156-66. doi: 10.1016/j.tmrv.2014.05.001. Epub 2014 May 15.
Despite its high prevalence, anemia often does not receive proper clinical attention, and detection, evaluation, and management of iron deficiency anemia and iron-restricted erythropoiesis can possibly be an unmet medical need. A multidisciplinary panel of clinicians with expertise in anemia management convened and reviewed recent published data on prevalence, etiology, and health implications of anemia as well as current therapeutic options and available guidelines on management of anemia across various patient populations and made recommendations on the detection, diagnostic approach, and management of anemia. The available evidence confirms that the prevalence of anemia is high across all populations, especially in hospitalized patients. Anemia is associated with worse clinical outcomes including longer length of hospital stay, diminished quality of life, and increased risk of morbidity and mortality, and it is a modifiable risk factor of allogeneic blood transfusion with its own inherent risks. Iron deficiency is usually present in anemic patients. An algorithm for detection and management of anemia was discussed, which incorporated iron study (with primary emphasis on transferrin saturation), serum creatinine and glomerular filtration rate, and vitamin B12 and folic acid measurements. Management strategies included iron therapy (oral or intravenous), erythropoiesis-stimulating agents, and referral as needed.
尽管贫血患病率很高,但往往未得到适当的临床关注,缺铁性贫血和铁限制红细胞生成的检测、评估及管理可能是一种未被满足的医疗需求。一个由在贫血管理方面具有专业知识的临床医生组成的多学科小组召开会议,回顾了最近发表的关于贫血患病率、病因及对健康影响的数据,以及当前针对不同患者群体的贫血治疗选择和可用管理指南,并就贫血的检测、诊断方法及管理提出了建议。现有证据证实,贫血在所有人群中患病率都很高,尤其是住院患者。贫血与更差的临床结局相关,包括住院时间延长、生活质量下降以及发病和死亡风险增加,并且它是同种异体输血的一个可改变的风险因素,而输血本身也有其内在风险。贫血患者通常存在缺铁情况。讨论了一种贫血检测和管理算法,该算法纳入了铁代谢研究(主要侧重于转铁蛋白饱和度)、血清肌酐和肾小球滤过率,以及维生素B12和叶酸测量。管理策略包括铁剂治疗(口服或静脉注射)、促红细胞生成剂,并根据需要进行转诊。